About AVT
Browse Articles
Authors
Customer Services

Case report

Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy

Robert Dennert, Sebastiaan Velthuis, Dirk Westermann, Dirk Donker, Simon Schalla, Robert-Jan van Suylen, Stephane Heymans

Corresponding author name: Stephane Heymans
Corresponding author e-mail: s.heymans@cardio.unimaas.nl

Citation: Antiviral Therapy 2010; 15:681-685
doi: 10.3851/IMP1563

Date accepted: 24 December 2009
Date published online: 25 June 2010

Abstract

Fulminant myocarditis is a rare inflammatory heart disease affecting relatively young adults. We describe a case of a 27-year-old male with acute onset severe heart failure. A rapid and accurate diagnostic approach suggested parvovirus B19 as the most probable cause for this fulminant viral myocarditis. Initial haemodynamic support, intensive immunosuppressive and antiviral therapy resulted in a complete recovery within 2 weeks. This case demonstrates the importance of a detailed diagnosis, allowing better classification of the underlying pathology and subsequent targeted treatment.

<< BACK

Copyright © Nucleus Group 2010. Part of the Nucleus Group of Companies.
Design and Technology by the Nucleus Group
Company registration No. 321 0712 (England & Wales). Registered Office address: 36 St Mary at Hill, London, EC3R 8DU.